{"title":"Clinical Validation of Cognivue® - A Computerized Alternative to the Montreal Cognitive Assessment Test","authors":"Fred Ma, Diego Cahn-Hidalgo","doi":"10.47275/2692-093x-116","DOIUrl":null,"url":null,"abstract":"Aims: To determine the utility of Cognivue ® compared to the MoCA for reliably assessing cognitive impairment (CI). Methods: Adults ≥55y completed two testing sessions 1-2 weeks apart during which both Cognivue ® and MoCA were conducted. Correlation analyses were performed for overall scores on each neuropsychological test and retest reliability was assessed via regression analyses. Results: 100 participants completed the testing sessions. A statistically significant positive correlation between overall scores on Cognivue ® and MoCA was found (r = 0.38; p<0.001). Test-retest reliability was greater for Cognivue ® than MoCA for participants initially classified as having no CI (87.3% vs. 73.1%). Regression analyses of test-retest reliability revealed a tighter and more linear pattern for Cognivue ® than MoCA, however a statistically significant regression fit for both was demonstrated (Cognivue ® : R2 = 0.439, r = 0.663; MoCA: R2 = 0.378, r = 0.615). Conclusions: Cognivue ® demonstrated comparable reliability to MoCA, thus providing an efficient, easy-to-use alternative for assessing CI.","PeriodicalId":93129,"journal":{"name":"Neurological sciences and neurosurgery","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurological sciences and neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47275/2692-093x-116","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: To determine the utility of Cognivue ® compared to the MoCA for reliably assessing cognitive impairment (CI). Methods: Adults ≥55y completed two testing sessions 1-2 weeks apart during which both Cognivue ® and MoCA were conducted. Correlation analyses were performed for overall scores on each neuropsychological test and retest reliability was assessed via regression analyses. Results: 100 participants completed the testing sessions. A statistically significant positive correlation between overall scores on Cognivue ® and MoCA was found (r = 0.38; p<0.001). Test-retest reliability was greater for Cognivue ® than MoCA for participants initially classified as having no CI (87.3% vs. 73.1%). Regression analyses of test-retest reliability revealed a tighter and more linear pattern for Cognivue ® than MoCA, however a statistically significant regression fit for both was demonstrated (Cognivue ® : R2 = 0.439, r = 0.663; MoCA: R2 = 0.378, r = 0.615). Conclusions: Cognivue ® demonstrated comparable reliability to MoCA, thus providing an efficient, easy-to-use alternative for assessing CI.